Diaceutics (DXRX) Competitors

Diaceutics (LON:DXRX) and ANGLE (LON:AGL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, community ranking, dividends, profitability and institutional ownership.

Which has better valuation & earnings, DXRX or AGL?

Diaceutics has higher revenue and earnings than ANGLE. Diaceutics is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Diaceutics	£26.09M	3.90	-£2.85M	-£0.03	-4,016.67
ANGLE	£2.02M	16.95	-£18.03M	-£0.07	-151.64

Does the MarketBeat Community favor DXRX or AGL?

ANGLE received 168 more outperform votes than Diaceutics when rated by MarketBeat users. However, 87.50% of users gave Diaceutics an outperform vote while only 62.33% of users gave ANGLE an outperform vote.

Company	Underperform	Outperform
Diaceutics	Outperform Votes 14 87.50%	Underperform Votes 2 12.50%
ANGLE	Outperform Votes 182 62.33%	Underperform Votes 110 37.67%

Which has more volatility & risk, DXRX or AGL?

Diaceutics has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, ANGLE has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500.

Do analysts recommend DXRX or AGL?

Diaceutics currently has a consensus price target of GBX 160, suggesting a potential upside of 32.78%. ANGLE has a consensus price target of GBX 70, suggesting a potential upside of 559.44%. Given ANGLE's higher possible upside, analysts clearly believe ANGLE is more favorable than Diaceutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Diaceutics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
ANGLE	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals and insiders believe in DXRX or AGL?

52.4% of Diaceutics shares are held by institutional investors. Comparatively, 18.8% of ANGLE shares are held by institutional investors. 34.3% of Diaceutics shares are held by company insiders. Comparatively, 16.2% of ANGLE shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Is DXRX or AGL more profitable?

ANGLE has a net margin of 0.00% compared to Diaceutics' net margin of -10.90%. Diaceutics' return on equity of -7.13% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Diaceutics	-10.90%	-7.13%	-6.06%
ANGLE	N/A	-63.75%	-29.89%

Does the media prefer DXRX or AGL?

In the previous week, Diaceutics had 1 more articles in the media than ANGLE. MarketBeat recorded 2 mentions for Diaceutics and 1 mentions for ANGLE. ANGLE's average media sentiment score of 0.75 beat Diaceutics' score of 0.00 indicating that ANGLE is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Diaceutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ANGLE	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Diaceutics beats ANGLE on 10 of the 16 factors compared between the two stocks.